Mealey's (September 6, 2018, 1:32 PM EDT) -- ATLANTA — Dismissal of a pharmaceutical company’s defamation suit for lack of personal jurisdiction was affirmed Sept. 5 by an 11th Circuit U.S. Court of Appeals panel, which found that failure to establish that the alleged defamatory online postings were accessed by anyone in Florida precluded conferring long-arm jurisdiction over the out-of-state defendant (Catalyst Pharmaceuticals Inc. v. James Fullerton, No. 17-15196, 11th Cir., 2018 U.S. App. LEXIS 25133)....